According to official data, sexually transmitted infections (STIs) are on the rise throughout the United States and show no signs of slowing. The Centers for Disease Control and Prevention (CDC) reported 2.53 million cases of chlamydia, gonorrhea, and syphilis in 2021. This is an increase of 7% from 2017 and almost 6% from 2020. While […]
Continue Reading
On Tuesday, April 4th, 2023, the US FDA granted Inflarx NV’s IF0G.F monoclonal antibody emergency-use authorization for the treatment of hospitalized COVID patients when initiated within 48 hours of receiving artificial life support. The US recorded portions of the German biopharmaceutical organization rose practically 25% to $4.70 after the ringer. Gohibic is an injection that […]
Continue Reading
GenoME, a health technology company based in Belfast, has raised 1.4 million pounds for its diagnostics platform for ovarian cancer early detection. The investment comes after the company raised 300,000 pounds in a pre-seed round in 2021, which helped it meet UK regulatory milestones. GenoME will use its new funds to finish testing its technology […]
Continue Reading
As a result of Prof. John Deanfield’s appointment as Government Champion for Personalised Prevention, a project to identify radical new approaches to prevent cardiovascular disease (CVD) and alleviate NHS pressure is in the works. The Secretary of State for Health and Social Care has asked Professor Deanfield, who is a professor of cardiology at University […]
Continue Reading
In the UK, a rare infectious disease found in cats has been discovered for the first time. Up to three British citizens may be affected by the fungal infection, which has only previously been discovered in South America and causes skin blisters in humans. It is unknown who the three Sporotrichosis victims were, but a […]
Continue Reading
Dr. Reddy’s Laboratories (DRL) has agreed to buy Mayne Pharma Group’s US generic prescription product portfolio for $90 million up front and up to $15 million in contingent payments. The acquisition will add limited competition products to DRL’s US retail prescription pharmaceutical business. According to IQVIA, the total addressable market in the United States for […]
Continue Reading
To help the failing healthcare system in Canada, the government has pledged nearly $149 billion in funding over ten years. In an announcement made on, February 14, 2023, the funding was presented as a system fix for the next generation. Canada’s hospitals have been fighting staff shortages and long wait times for treatment for months. […]
Continue Reading
A new study has been providing even more proof that sugar is bad for your health. The study, which was published in the journal BMC Medicine, found that people are more likely to get heart disease and stroke if they eat a diet high in free sugars. Free sugars are the sugar that is added […]
Continue Reading
The use of certain qualified health claims regarding the association between the consumption of high flavanol cocoa powder and a lower risk of cardiovascular disease is not anticipated to be objected by the US FDA. However, the US FDA determined that there is very little credible scientific evidence for the reduced risk, which will restrict […]
Continue Reading
According to an industry body, pharmaceutical companies AbbVie and Eli Lilly had withdrawn from Britain’s voluntary medicines pricing agreement. According to a statement released by the Association of the British Pharmaceutical Industry (ABPI), businesses are increasingly arguing that it is no longer possible to justify the UK’s “voluntary scheme” to global boardrooms and investors as […]
Continue Reading